Table 4.
Characteristics Preoperative MH (n) | ILM-Peeled Eyes (N = 18) | Non–ILM-Peeled Eyes (N = 6) | P |
---|---|---|---|
Stage II | 3 | 5 | |
Stage III | 9 | 1 | |
Stage IV | 2 | 0 | |
Recurrent hole | 4 | 0 | |
Preoperative MH size (μm), mean ± SD (range) | 331.38 ± 127.72 (180–614) | 216 ± 90.15 (160–320) | 0.12 |
Preoperative BCVA, mean (range) | 20/112 (20/40–20/400) | 20/67 (20/40–20/80) | 0.22 |
Postoperative BCVA, Mean (range) | 20/38 (20/25–20/70) | 20/29 (20/25–20/40) | 0.09 |
tMV (mm3), mean ± SD (range) | 2.26 ± (0.17) (2.01–2.51) | 2.32 ± 0.12 (2.30–2.49) | 0.46 |
iMV (mm3), mean ± SD (range) | 0.68 ± 0.12 (0.48–0.88) | 0.74 ± 0.10 (0.63–0.89) | 0.31 |
CFT (μm), mean ± SD (range) | 172.61 ± 30.09 (149–239) | 180.56 ± 26.87 (155–213) | 0.57 |
IS-OS defect size (μm), mean ± SD (range) | 29.63 ± 24.01 (0–75.4) | 18.20 ± 14.15 (0–28.6) | 0.28 |
iMV, inner retinal macular volume for central 3 mm area; MH, macular hole; P value, comparing the mean values using unpaired t-test; tMV, tMV for central 3 mm area.